Nasal polyps

Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(suppl s29):1-464. Abstract

Rank MA, Chu DK, Bognanni A, et al. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2023 Feb;151(2):386-98.Full text  Abstract

Rimmer J, Fokkens W, Chong LY, et al. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014;(12):CD006991.Full text  Abstract

1. ​Cardesa A, Alos L, Nadal A, et al. Nasal cavity and paranasal sinuses. In: Cardesa A, Slootweg P, Gale N, et al. eds. Pathology of the head and neck. Berlin, Heidelberg: Springer; 2017.Full text

2. Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 Feb 20;58(suppl s29):1-464. Abstract

3. Langdon C, Mullol J. Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy. 2016 Mar 14;9:45-53.Full text  Abstract

4. Rank MA, Chu DK, Bognanni A, et al. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2023 Feb;151(2):386-98.Full text  Abstract

5. Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):565-72. Abstract

6. Philpott CM, Erskine S, Hopkins C, et al. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study. Respir Res. 2018 Jun 27;19(1):129.Full text  Abstract

7. Johnson BJ, Choby GW, O'Brien EK. Chronic rhinosinusitis in patients with cystic fibrosis - current management and new treatments. Laryngoscope Investig Otolaryngol. 2020 Jun;5(3):368-74.Full text  Abstract

8. Bailly C, Helbecque N, Hénichart JP, et al. Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligand. J Mol Recognit. 1990 Feb;3(1):26-35.Full text  Abstract

9. Yoo F, Suh JD. What is the evidence for genetics in chronic rhinosinusitis? Curr Opin Otolaryngol Head Neck Surg. 2017 Feb;25(1):54-63. Abstract

10. Oakley GM, Curtin K, Orb Q, et al. Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment. Int Forum Allergy Rhinol. 2015 Apr;5(4):276-82.Full text  Abstract

11. Bohman A, Oscarsson M, Holmberg K, et al. Heredity of nasal polyps. Rhinology. 2015 Mar;53(1):25-8. Abstract

12. Bohman A, Juodakis J, Oscarsson M, et al. A family-based genome-wide association study of chronic rhinosinusitis with nasal polyps implicates several genes in the disease pathogenesis. PLoS One. 2017;12(12):e0185244.Full text  Abstract

13. Samter M. Nasal polyps: their relationship to allergy, particularly to bronchial asthma. Med Clin North Am. 1958 Jan;42(1):175-9. Abstract

14. Bakhshaee M, Fereidouni M, Nourollahian M, et al. The presence of fungal-specific IgE in serum and sinonasal tissue among patients with sinonasal polyposis. Eur Arch Otorhinolaryngol. 2014 Nov;271(11):2871-5.Full text  Abstract

15. Hoyt AE, Borish L, Gurrola J, et al. Allergic fungal rhinosinusitis. J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):599-604. Abstract

16. Dykewicz MS, Rodrigues JM, Slavin RG. Allergic fungal rhinosinusitis. J Allergy Clin Immunol. 2018 Aug;142(2):341-51. Abstract

17. Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016 Nov;138(5):1344-53.Full text  Abstract

18. Bachert C, Zhang N, Holtappels G, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol. 2010 Nov;126(5):962-8. Abstract

19. Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013 Jan;131(1):110-6.e1. Abstract

20. Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011 Nov;128(5):989-95.e1-8. Abstract

21. Bachert C, Sousa AR, Lund VJ, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol. 2017 Oct;140(4):1024-31.e14. Abstract

22. Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016 Feb 2;315(5):469-79.Full text  Abstract

23. Fijolek J, Radzikowska E. Eosinophilic granulomatosis with polyangiitis - advances in pathogenesis, diagnosis, and treatment. Front Med (Lausanne). 2023;10:1145257.Full text  Abstract

24. Montone KT. Pathology of fungal rhinosinusitis: a review. Head Neck Pathol. 2016 Mar;10(1):40-6. Abstract

25. Eckhoff A, Cox D, Luk L, et al. Unilateral versus bilateral sinonasal disease: considerations in differential diagnosis and workup. Laryngoscope. 2020 Apr;130(4):E116-21.Full text  Abstract

26. Hopkins C. Chronic Rhinosinusitis with nasal polyps. N Engl J Med. 2019 Jul 4;381(1):55-63. Abstract

27. Scadding G, Hellings P, Alobid I, et al. Diagnostic tools in Rhinology EAACI position paper. Clin Transl Allergy. 2011 Jun 10;1(1):2.Full text  Abstract

28. Gevaert P, De Craemer J, Bachert C, et al. European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis. Allergy. 2023 Apr;78(4):912-22.Full text  Abstract

29. Jackson DJ, Akuthota P, Roufosse F. Eosinophils and eosinophilic immune dysfunction in health and disease. Eur Respir Rev. 2022 Mar 31;31(163):210150.Full text  Abstract

30. Miller B, Mirakian R, Gane S, et al. Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease: asthma and rhinitis. Clin Exp Allergy. 2013 Aug;43(8):874-80.Full text  Abstract

31. Graefe H, Roebke C, Schäfer D, et al. Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination. J Allergy (Cairo). 2012;2012:817910.Full text  Abstract

32. Doty RL, Shaman P, Kimmelman CP, et al. University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984 Feb;94(2 Pt 1):176-8. Abstract

33. Diamantopoulos II, Jones NS, Lowe J. All nasal polyps need histological examination: an audit-based appraisal of clinical practice. J Laryngol Otol. 2000 Oct;114(10):755-9. Abstract

34. Lee AW, Foo W, Law SC, et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J. 1997 Dec;3(4):355-61.Full text  Abstract

35. Liu L, Liang S, Li L, et al. Prognostic impact of magnetic resonance imaging-detected cranial nerve involvement in nasopharyngeal carcinoma. Cancer. 2009 May 1;115(9):1995-2003.Full text  Abstract

36. Head K, Chong LY, Hopkins C, et al. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016 Apr 26;4:CD011992.Full text  Abstract

37. Head K, Chong LY, Hopkins C, et al. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016 Apr 26;4:CD011991.Full text  Abstract

38. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010 May;125(5):1069-76.e4. Abstract

39. Pinto Bezerra Soter AC, Bezerra TF, Pezato R, et al. Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps. Rhinology. 2017 Jun 1;55(2):175-80. Abstract

40. Chong LY, Head K, Hopkins C, et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;(4):CD011995.Full text  Abstract

41. Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019 Dec;74(12):2312-9.Full text  Abstract

42. Safety update: dupilumab and ocular adverse reactions. Drug Ther Bull. 2023 Jan;61(1):6.Full text  Abstract

43. Punekar YS, Ahmad A, Saleh HA. Estimating the effect of nasal steroid treatment on repeat polypectomies: survival time analysis using the General Practice Research Database. Rhinology. 2011 Jun;49(2):190-4. Abstract

44. Rimmer J, Fokkens W, Chong LY, et al. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014;(12):CD006991.Full text  Abstract

45. Chong LY, Piromchai P, Sharp S, et al. Biologics for chronic rhinosinusitis. Cochrane Database Syst Rev. 2021 Mar 12;3:CD013513.Full text  Abstract

46. ClinicalTrials.gov. Efficacy and safety of tezepelumab in participants with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT). ClinicalTrials.gov identifier: NCT04851964. Apr 2022 [internet publication].Full text

47. ClinicalTrials.gov. Benralizumab effect on severe chronic rhinosinusitis with eosinophilic polyposis. ClinicalTrials.gov identifier: NCT03450083. Feb 2021 [internet publication].Full text

48. ClinicalTrials.gov. Efficacy and safety study of benralizumab in patient with eosinophilic chronic rhinosinusitis with nasal polyps (ORCHID). ClinicalTrials.gov identifier: NCT04157335. May 2022 [internet publication].Full text

49. Santomasi C, Buonamico E, Dragonieri S, et al. Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study. Acta Biomed. 2023 Feb 13;94(1):e2023028.Full text  Abstract

50. Desrosiers M, Evans GA, Keith PK, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol. 2011 Feb 10;7(1):2.Full text  Abstract